(Reuters) -British pharmaceutical giant GSK said on Wednesday it would cap out-of-pocket costs for all its inhaled asthma and chronic lung disease medicines at $35 per month for eligible patients in ...
On Jan. 21, 2024, a 22-year-old Wisconsin man died from a severe asthma attack days after he was unable to purchase his regular inhaler due to a sudden price hike and opted to pay his rent instead.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results